26
Participants
Start Date
December 11, 2023
Primary Completion Date
February 1, 2026
Study Completion Date
April 1, 2026
Icatibant
Icatibant will be administered with an infusion rate of 100µg/kg/h for 15 minutes before their hemodialysis session (pre-infusion) and 50µg/kg/h during their routine hemodialysis session (maintenance infusion).
Placebo
0.9% sodium chloride will be administered as the same rate as icatibant
RECRUITING
Vanderbilt Fresenius, Nashville
Pharvaris Netherlands B.V.
INDUSTRY
Renal Research Institute
OTHER
Vanderbilt University Medical Center
OTHER